+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Bone Grafts & Substitutes Market Size, Share & Trends Analysis Report by Product (Allograft, Synthetic), by Application (Spinal Fusion, Dental, Craniomaxillofacial, Foot & Ankle, Joint Reconstruction, Long Bone), and Segment Forecasts, 2020 - 2027

  • ID: 5144634
  • Report
  • August 2020
  • Region: Asia Pacific
  • 100 pages
  • Grand View Research

FEATURED COMPANIES

  • Baxter
  • DePuy Synthes, Inc.
  • Geistlich Pharma AG
  • Medtronic
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
Asia Pacific Bone Grafts & Substitutes Market Growth & Trends

The Asia Pacific bone grafts and substitutes market size is expected to reach USD 922.4 million by 2027, expanding at a CAGR of 7.1%. Increasing the incidence of bone disorders due to road accidents and sports injuries is driving the market. Increasing demand for the development of biocompatible bone grafts in order to reduce adverse reaction is driving demand for synthetic grafts.

The industry players are continuously trying to develop new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in June 2019, Biogennix received 510(K) clearance from USFDA for Agilon, which is fully biocompatible with human bone. In August 2019, NanoFUSE biologics marked its presence in Thailand with FDA approved NanoFUSE biologics, a bioactive glass with a demineralized bone matrix.

Asia Pacific Bone Grafts & Substitutes Market Report Highlights
  • In terms of revenue, allograft dominated the product segment in 2019. The growth can be attributed to its increased usage in medical procedures and product innovation.
  • The Demineralized Bone Matrix (DBM) segment dominated the allografts segment as of 2019 owing to its increased commercial accessibility in a number of standard forms and sources.
  • On the basis of application, the spinal fusion segment held the largest revenue share in 2019 owing to the growing number of spinal fusion procedures and new product approvals for the same.
  • The dental segment is expected to show lucrative growth over the forecast period. The growth can be attributed to the increasing number of dental implant surgeries and product availability.
  • An increasing number of government initiatives and medical tourism is expected to propel market growth. Moreover, the growing number of bone and joint disorders due to the increasing aging population is further increasing the growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baxter
  • DePuy Synthes, Inc.
  • Geistlich Pharma AG
  • Medtronic
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in Asia Pacific
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Report Objectives

Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Asia Pacific Bone grafts & substitutes market Outlook, 2016-2027 (USD Million)
2.2 Asia Pacific Bone grafts & substitutes Market Summary, 2019

Chapter 3 Asia Pacific Bone grafts & substitutes Market Variables, Trends & Scope
3.1 Technology Timeline Overview
3.1.1 Technology Timeline Asia Pacific Bone grafts & substitutes changing technology & adoption
3.2 Asia Pacific Bone grafts & substitutes Market Dynamics
3.2.1 Market driver analysis
3.2.1.1 Rising incidence of bone & joint disorders
3.2.1.2 Advent of biocompatible synthetic graft
3.2.1.3 Rising demand for dental bone grafts
3.2.1.4 Technological advancement
3.2.1.5 Rising geriatric population
3.2.2 Market restraint analysis
3.2.2.1 Stringent regulatory guidelines
3.2.2.2 Risk of disease transmission
3.2.2.3 High cost of bone grafts and substitutes
3.3 Asia Pacific Bone grafts & substitutes Market Analysis Tools: Porters
3.3.1 Supplier POWER: Low
3.3.2 Buyer POWER:-high
3.3.3 THREAT OF SUBSTITUTES: moderate
3.3.4 THREAT OF NEW ENTRANTS: high
3.3.5 Competitive Rivalry: high
3.4 PESTEL Analysis
3.4.1 Political Landscape
3.4.2 Economic Landscape
3.4.3 Technology Landscape
3.4.4 Social Landscape

Chapter 4 Asia Pacific Bone grafts & substitutes Market: Competitive Analysis
4.1 Innovators
4.2 Key Company Market Share Analysis, 2019
4.3 Market Leaders
4.4 Market Leaders By Product Segment
4.5 Major Deals & Strategic Alliances Analysis
4.5.1 product launch
4.5.2 Acquisitions
4.5.3 Product Approval
4.5.4 Partnership & Collaborations
4.6 Estimated Surgery Cost in Southeast Asia
4.7 Bone Grafts & Substitutes Surgery Volume in Southeast Asia (%, 2019, Estimated)

Chapter 5 Asia Pacific Bone grafts & substitutes Market: Product Estimates & Trend Analysis
5.1 Product Market Share Analysis, 2019 & 2027
5.2 Product Dashboard
5.2.1 Allograft
5.2.1.1 Allograft market estimates and forecasts, 2016-2027 (USD Million)
5.2.1.2 Demineralized Bone Matrix (DBM)
5.2.1.3 Demineralized Bone Matrix (DBM) market estimates and forecasts, 2016-2027 (USD Million)
5.2.1.4 Others
5.2.1.5 Others market estimates and forecasts, 2016-2027 (USD Million)
5.2.2 Synthetic
5.2.2.1 Synthetic market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.2 Ceramic
5.2.2.3 Ceramic market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.4 HAP
5.2.2.5 HAP market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.6 ß-TCP
5.2.2.7 ß-TCP market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.8 α-tricalcium phosphate (α-TCP)
5.2.2.9 Α-TCP market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.10 Bi-phasic calcium phosphates (BCP)
5.2.2.11 Bi-phasic calcium phosphates (BCP) market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.12 Others
5.2.2.13 Others market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.14 Composite
5.2.2.15 Composite market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.16 Polymers
5.2.2.17 Polymers market estimates and forecasts, 2016-2027 (USD Million)
5.2.2.18 BMP
5.2.2.19 BMP market estimates and forecasts, 2016-2027 (USD Million)

Chapter 6 Asia Pacific Bone grafts & substitutes Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2019&2027
6.2 Application Dashboard
6.3 Craniomaxillofacial
6.3.1 Craniomaxillofacial market estimates and forecasts, 2016-2027 (USD Million)
6.4 Dental
6.4.1 Dental market estimates and forecasts, 2016-2027 (USD Million)
6.5 Foot & Ankle
6.5.1 Foot & Ankle market estimates and forecasts, 2016-2027 (USD Million)
6.6 Joint Reconstruction
6.6.1 Joint Reconstruction market estimates and forecasts, 2016-2027 (USD Million)
6.7 Long Bone
6.7.1 Long Bone market estimates and forecasts, 2016-2027 (USD Million)
6.8 Spinal Fusion
6.8.1 Spinal Fusion market estimates and forecasts, 2016-2027 (USD Million)

Chapter 7 Asia Pacific Bone grafts & substitutes Market: Country Estimates & Trend Analysis, By, Product, & Application
7.1 Regional Market Snapshot
7.2 Asia Pacific
7.2.1 Asia Pacific Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.2 Japan
7.2.2.1 Japan Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.3 China
7.2.3.1 China Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.4 India
7.2.4.1 India Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.5 Australia
7.2.5.1 Australia Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.6 South Korea
7.2.6.1 South Korea Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.7 Indonesia
7.2.7.1 Indonesia Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.8 Malaysia
7.2.8.1 Malaysia Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.9 Singapore
7.2.9.1 Singapore Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.10 Philippines
7.2.10.1 Philippines Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.11 Thailand
7.2.11.1 Thailand Bone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)
7.2.12 Vietnam
7.2.12.1 VietnamBone grafts & substitutes market estimates and forecasts, 2016-2027 (USD Million)

Chapter 8 Company Profiles
8.1 Baxter
8.1.1 Company overview
8.1.2 Financial Performance
8.1.3 Product benchmarking
8.1.4 Strategic Initiatives
8.2 DePuy Synthes, Inc.
8.2.1 Company overview
8.2.2 Financial Performance
8.2.3 Product benchmarking
8.2.4 Strategic Initiatives
8.3 Medtronic
8.3.1 Company overview
8.3.2 Financial Performance
8.3.3 Product benchmarking
8.3.4 Strategic Initiatives
8.4 Nuvasive, Inc.
8.4.1 Company overview
8.4.2 Financial Performance
8.4.3 Product benchmarking
8.4.4 Strategic Initiatives
8.5 Orthofix Holdings, Inc.
8.5.1 Company overview
8.5.2 Financial Performance
8.5.3 Product benchmarking
8.5.4 Strategic Initiatives
8.6 Smith & Nephew, Inc.
8.6.1 Company overview
8.6.2 Financial Performance
8.6.3 Product benchmarking
8.6.4 Strategic Initiatives
8.7 Stryker Corporation
8.7.1 Company overview
8.7.2 Financial Performance
8.7.3 Product benchmarking
8.7.2 Strategic Initiatives
8.8 Wright Medical Group N.V.
8.8.1 Company overview
8.8.2 Financial Performance
8.8.3 Product benchmarking
8.8.4 Strategic Initiatives
8.9 Zimmer Biomet
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 Geistlich Pharma AG
8.10.1 Company overview
8.10.2 Product benchmarking
Note: Product cover images may vary from those shown
  • Baxter
  • DePuy Synthes, Inc.
  • Medtronic
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • Smith & Nephew, Inc.
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet
  • Geistlich Pharma AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll